Read + Share
Casulo C, Dixon JG, Le-Rademacher J, Hoster E, et al. Validation of POD24 as a robust early clinical end point of poor survival in FL
from 5225 patients on 13 clinical trials. Blood 2022;139:1684-1693.
PMID: 34614146
|
 |
|
Casulo C, Dixon JG, Le-Rademacher J, Hoster E, et al. Validation of POD24 as a robust early clinical end point of poor survival in FL
from 5225 patients on 13 clinical trials. Blood 2022;139:1684-1693.
PMID: 34614146
|
|
|
|